New Delhi: The National Pharmaceutical Pricing Authority (NPPA), India’s drug-price regulator, has approved a price increase of over 50 per cent for essential drugs used to treat medical conditions like asthma, glaucoma, thalassemia, tuberculosis, and mental health issues. According to the Ministry of Health and Family Welfare, the decision was made on October 8, during a full Authority meeting, utilising the extraordinary powers granted under Para 19 of the Drugs (Prices Control) Order, 2013.
Why Were The Prices Revised?The NPPA revised the ceiling prices of eight scheduled drugs to meet the “twin objectives of availability and affordability”, the authority claimed in a press release. “Most of these drugs are low-cost and generally used as first-line treatment crucial to the public health programmes of the country.”Eleven formulations for which ceiling prices have been revised include benzylpenicillin (10 lakh IU injection), atropine injection (0.6 mg per ml), streptomycin powder (for injection 750 mg and 1000 mg), salbutamol tablet (2 mg and 4 mg), respirator solution (5 mg per ml), Pilocarpine 2% drops, Cefadroxil tablet (500 mg), Desferrioxamine (500 mg for injection) and Lithium tablets (300 mg).These medications are often used as first-line treatments in public health programs, and the price adjustments aim to prevent shortages or market withdrawal due to production challenges. How Much The Medicines Will Cost Now?The cost of these medicines will range Rs 1.02 per ml solution to Rs 16.25 per ml drop, with the exception of a more expensive Desferroxamine that will cost a little over Rs 280 per vial.Notably, the medicines for which the prices have been increased are not very expensive to begin with. So the 50 per cent increase in ceiling prices is unlikely to hit people very hard. Similar measures were taken in 2019 and 2021, when ceiling prices for 21 and 9 formulations, respectively, were increased by 50 per cent. These interventions highlight the NPPA's ongoing efforts to strike a balance between maintaining drug affordability and ensuring their availability, particularly for treatments that are crucial to the nation's healthcare system.You may also like
Man spots detail on hotel room door that's 'like something from horror film'
Liverpool vs Chelsea referee drew angry response from Virgil van Dijk over controversial decision
Delhi court extends interim bail of Engineer Rashid till Oct 28
John W. Henry brutally told he had bought 'wrong club' days after Liverpool purchase
Air India Flight To Chicago Lands In Canada After Bomb Threat
Pep Guardiola to welcome £12.5million midfielder to Man City in January transfer window
Bengaluru weather leads to heavy flooding at Manyata Tech Park: Netizens demand WFH options as video goes viral
'Butcher surgeon Ian Paterson stole my sister's life - I hope he rots in prison'
Is Flavoured Yogurt, Milk And Curd Actually Good For Your Gut Health? Nutritionist Answers
Indian Real Estate Attracts Whopping Rs 74,815 Crore in Equity Investments This Year: CBRE
By-elections to four Assembly seats in Bihar on November 13
UAE amends over 60 laws to support SME growth
Rajnath Singh lays foundation of Indian Navy's Very Low Frequency station in Telangana; Know its relevance
Noah Lyles signs deal to face NFL speedster who taunted him over illness
Here's why Kartik Aaryan wants Vidya Balan, not Manjulika
Indian Army launches month-long tribute to 1962 Battle of Walong heroes
US Space Force's mysterious X-37B mini-shuttle on 'groundbreaking' mission above Earth
Telugu superstar Sai Durgha Tej's new movie #SDT18: First look video released
CBFC stops Akshay Kumar's no smoking 'Fu Fu Nandu' ad from theatres after 6 years; here's why
Effectively and safely remove black mould in your home – without bleach